Travere Therapeutics, Inc.
Get $10 bonus on your first $100 deposit for TVTX
Get $10 bonus on your first $100 deposit for TVTX
Travere Therapeutics, Inc. (TVTX) Stock Competitors & Peer Comparison
See (TVTX) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TVTX | $40.08 | +1.37% | 3.8B | -71.53 | -$0.57 | N/A |
| VRTX | $439.44 | +0.87% | 112.2B | 28.78 | $15.33 | N/A |
| REGN | $751.38 | +0.72% | 78B | 18.09 | $41.49 | +0.48% |
| VRNA | $106.91 | +0.11% | 72.7B | -102.80 | -$1.04 | N/A |
| ARGX | $838.58 | +1.23% | 52.5B | 43.32 | $19.60 | N/A |
| SGEN | $228.74 | -0.07% | 43.2B | -57.19 | -$4.00 | N/A |
| ALNY | $311.73 | -2.63% | 41.1B | 132.33 | $2.34 | N/A |
| INSM | $143.52 | +0.51% | 31.1B | -22.47 | -$6.43 | N/A |
| RVMD | $149.50 | +0.15% | 29.5B | -24.98 | -$5.95 | N/A |
| BNTX | $104.65 | +2.48% | 25.9B | -18.78 | -$5.48 | N/A |
Stock Comparison
TVTX vs VRTX Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, VRTX has a market cap of 112.2B. Regarding current trading prices, TVTX is priced at $40.08, while VRTX trades at $439.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas VRTX's P/E ratio is 28.78. In terms of profitability, TVTX's ROE is -0.79%, compared to VRTX's ROE of +0.23%. Regarding short-term risk, TVTX is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check VRTX's competition here
TVTX vs REGN Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, REGN has a market cap of 78B. Regarding current trading prices, TVTX is priced at $40.08, while REGN trades at $751.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas REGN's P/E ratio is 18.09. In terms of profitability, TVTX's ROE is -0.79%, compared to REGN's ROE of +0.15%. Regarding short-term risk, TVTX is more volatile compared to REGN. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check REGN's competition here
TVTX vs VRNA Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, VRNA has a market cap of 72.7B. Regarding current trading prices, TVTX is priced at $40.08, while VRNA trades at $106.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas VRNA's P/E ratio is -102.80. In terms of profitability, TVTX's ROE is -0.79%, compared to VRNA's ROE of -0.13%. Regarding short-term risk, TVTX is more volatile compared to VRNA. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check VRNA's competition here
TVTX vs ARGX Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, ARGX has a market cap of 52.5B. Regarding current trading prices, TVTX is priced at $40.08, while ARGX trades at $838.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas ARGX's P/E ratio is 43.32. In terms of profitability, TVTX's ROE is -0.79%, compared to ARGX's ROE of +0.34%. Regarding short-term risk, TVTX is more volatile compared to ARGX. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check ARGX's competition here
TVTX vs SGEN Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, SGEN has a market cap of 43.2B. Regarding current trading prices, TVTX is priced at $40.08, while SGEN trades at $228.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas SGEN's P/E ratio is -57.19. In terms of profitability, TVTX's ROE is -0.79%, compared to SGEN's ROE of -0.21%. Regarding short-term risk, TVTX is more volatile compared to SGEN. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check SGEN's competition here
TVTX vs ALNY Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, ALNY has a market cap of 41.1B. Regarding current trading prices, TVTX is priced at $40.08, while ALNY trades at $311.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas ALNY's P/E ratio is 132.33. In terms of profitability, TVTX's ROE is -0.79%, compared to ALNY's ROE of +0.90%. Regarding short-term risk, TVTX is more volatile compared to ALNY. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check ALNY's competition here
TVTX vs INSM Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, INSM has a market cap of 31.1B. Regarding current trading prices, TVTX is priced at $40.08, while INSM trades at $143.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas INSM's P/E ratio is -22.47. In terms of profitability, TVTX's ROE is -0.79%, compared to INSM's ROE of -1.68%. Regarding short-term risk, TVTX is more volatile compared to INSM. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check INSM's competition here
TVTX vs RVMD Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, RVMD has a market cap of 29.5B. Regarding current trading prices, TVTX is priced at $40.08, while RVMD trades at $149.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas RVMD's P/E ratio is -24.98. In terms of profitability, TVTX's ROE is -0.79%, compared to RVMD's ROE of -0.63%. Regarding short-term risk, TVTX is more volatile compared to RVMD. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check RVMD's competition here
TVTX vs BNTX Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, BNTX has a market cap of 25.9B. Regarding current trading prices, TVTX is priced at $40.08, while BNTX trades at $104.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas BNTX's P/E ratio is -18.78. In terms of profitability, TVTX's ROE is -0.79%, compared to BNTX's ROE of -0.06%. Regarding short-term risk, TVTX is more volatile compared to BNTX. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check BNTX's competition here
TVTX vs UTHR Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, UTHR has a market cap of 25.8B. Regarding current trading prices, TVTX is priced at $40.08, while UTHR trades at $576.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas UTHR's P/E ratio is 21.13. In terms of profitability, TVTX's ROE is -0.79%, compared to UTHR's ROE of +0.19%. Regarding short-term risk, TVTX is more volatile compared to UTHR. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check UTHR's competition here
TVTX vs RPRX Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, RPRX has a market cap of 21.4B. Regarding current trading prices, TVTX is priced at $40.08, while RPRX trades at $49.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas RPRX's P/E ratio is 28.09. In terms of profitability, TVTX's ROE is -0.79%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, TVTX is more volatile compared to RPRX. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check RPRX's competition here
TVTX vs ROIV Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, ROIV has a market cap of 21.3B. Regarding current trading prices, TVTX is priced at $40.08, while ROIV trades at $29.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas ROIV's P/E ratio is -25.50. In terms of profitability, TVTX's ROE is -0.79%, compared to ROIV's ROE of -0.18%. Regarding short-term risk, TVTX is more volatile compared to ROIV. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check ROIV's competition here
TVTX vs MRNA Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, MRNA has a market cap of 21.2B. Regarding current trading prices, TVTX is priced at $40.08, while MRNA trades at $54.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas MRNA's P/E ratio is -7.40. In terms of profitability, TVTX's ROE is -0.79%, compared to MRNA's ROE of -0.30%. Regarding short-term risk, TVTX is less volatile compared to MRNA. This indicates potentially lower risk in terms of short-term price fluctuations for TVTX.Check MRNA's competition here
TVTX vs BGNE Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, BGNE has a market cap of 20.2B. Regarding current trading prices, TVTX is priced at $40.08, while BGNE trades at $184.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas BGNE's P/E ratio is -22.55. In terms of profitability, TVTX's ROE is -0.79%, compared to BGNE's ROE of +0.07%. Regarding short-term risk, TVTX is more volatile compared to BGNE. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check BGNE's competition here
TVTX vs INCY Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, INCY has a market cap of 19.5B. Regarding current trading prices, TVTX is priced at $40.08, while INCY trades at $97.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas INCY's P/E ratio is 15.26. In terms of profitability, TVTX's ROE is -0.79%, compared to INCY's ROE of +0.29%. Regarding short-term risk, TVTX is more volatile compared to INCY. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check INCY's competition here
TVTX vs DNA-WT Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, DNA-WT has a market cap of 18.7B. Regarding current trading prices, TVTX is priced at $40.08, while DNA-WT trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas DNA-WT's P/E ratio is N/A. In terms of profitability, TVTX's ROE is -0.79%, compared to DNA-WT's ROE of -0.54%. Regarding short-term risk, TVTX is less volatile compared to DNA-WT. This indicates potentially lower risk in terms of short-term price fluctuations for TVTX.Check DNA-WT's competition here
TVTX vs SMMT Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, SMMT has a market cap of 18.7B. Regarding current trading prices, TVTX is priced at $40.08, while SMMT trades at $25.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas SMMT's P/E ratio is -17.47. In terms of profitability, TVTX's ROE is -0.79%, compared to SMMT's ROE of -2.97%. Regarding short-term risk, TVTX is less volatile compared to SMMT. This indicates potentially lower risk in terms of short-term price fluctuations for TVTX.Check SMMT's competition here
TVTX vs GMAB Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, GMAB has a market cap of 17.6B. Regarding current trading prices, TVTX is priced at $40.08, while GMAB trades at $28.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas GMAB's P/E ratio is 18.56. In terms of profitability, TVTX's ROE is -0.79%, compared to GMAB's ROE of +0.14%. Regarding short-term risk, TVTX is more volatile compared to GMAB. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check GMAB's competition here
TVTX vs ASND Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, ASND has a market cap of 15B. Regarding current trading prices, TVTX is priced at $40.08, while ASND trades at $246.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas ASND's P/E ratio is -55.56. In terms of profitability, TVTX's ROE is -0.79%, compared to ASND's ROE of +1.28%. Regarding short-term risk, TVTX is more volatile compared to ASND. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check ASND's competition here
TVTX vs BBIO Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, BBIO has a market cap of 14.9B. Regarding current trading prices, TVTX is priced at $40.08, while BBIO trades at $76.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas BBIO's P/E ratio is -20.30. In terms of profitability, TVTX's ROE is -0.79%, compared to BBIO's ROE of +0.39%. Regarding short-term risk, TVTX is more volatile compared to BBIO. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check BBIO's competition here
TVTX vs KRTX Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, KRTX has a market cap of 12.6B. Regarding current trading prices, TVTX is priced at $40.08, while KRTX trades at $329.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas KRTX's P/E ratio is -28.09. In terms of profitability, TVTX's ROE is -0.79%, compared to KRTX's ROE of -0.36%. Regarding short-term risk, TVTX is more volatile compared to KRTX. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check KRTX's competition here
TVTX vs JAZZ Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, JAZZ has a market cap of 12.5B. Regarding current trading prices, TVTX is priced at $40.08, while JAZZ trades at $203.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas JAZZ's P/E ratio is -34.83. In terms of profitability, TVTX's ROE is -0.79%, compared to JAZZ's ROE of -0.09%. Regarding short-term risk, TVTX is more volatile compared to JAZZ. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check JAZZ's competition here
TVTX vs IONS Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, IONS has a market cap of 12.5B. Regarding current trading prices, TVTX is priced at $40.08, while IONS trades at $75.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas IONS's P/E ratio is -31.81. In terms of profitability, TVTX's ROE is -0.79%, compared to IONS's ROE of -0.69%. Regarding short-term risk, TVTX is more volatile compared to IONS. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check IONS's competition here
TVTX vs MDGL Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, MDGL has a market cap of 12.2B. Regarding current trading prices, TVTX is priced at $40.08, while MDGL trades at $527.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas MDGL's P/E ratio is -41.37. In terms of profitability, TVTX's ROE is -0.79%, compared to MDGL's ROE of -0.44%. Regarding short-term risk, TVTX is more volatile compared to MDGL. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check MDGL's competition here
TVTX vs EXEL Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, EXEL has a market cap of 11.7B. Regarding current trading prices, TVTX is priced at $40.08, while EXEL trades at $43.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas EXEL's P/E ratio is 16.15. In terms of profitability, TVTX's ROE is -0.79%, compared to EXEL's ROE of +0.37%. Regarding short-term risk, TVTX is more volatile compared to EXEL. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check EXEL's competition here
TVTX vs RNAM Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, RNAM has a market cap of 11.3B. Regarding current trading prices, TVTX is priced at $40.08, while RNAM trades at $72.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas RNAM's P/E ratio is -17.39. In terms of profitability, TVTX's ROE is -0.79%, compared to RNAM's ROE of -0.45%. Regarding short-term risk, TVTX is more volatile compared to RNAM. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check RNAM's competition here
TVTX vs BMRN Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, BMRN has a market cap of 10.5B. Regarding current trading prices, TVTX is priced at $40.08, while BMRN trades at $55.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas BMRN's P/E ratio is 30.36. In terms of profitability, TVTX's ROE is -0.79%, compared to BMRN's ROE of +0.06%. Regarding short-term risk, TVTX is more volatile compared to BMRN. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check BMRN's competition here
TVTX vs ARWR Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, ARWR has a market cap of 9.7B. Regarding current trading prices, TVTX is priced at $40.08, while ARWR trades at $70.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas ARWR's P/E ratio is 43.44. In terms of profitability, TVTX's ROE is -0.79%, compared to ARWR's ROE of +0.36%. Regarding short-term risk, TVTX is more volatile compared to ARWR. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check ARWR's competition here
TVTX vs AXSM Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, AXSM has a market cap of 9.7B. Regarding current trading prices, TVTX is priced at $40.08, while AXSM trades at $188.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas AXSM's P/E ratio is -51.22. In terms of profitability, TVTX's ROE is -0.79%, compared to AXSM's ROE of -2.54%. Regarding short-term risk, TVTX is more volatile compared to AXSM. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check AXSM's competition here
TVTX vs RXDX Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, RXDX has a market cap of 9.6B. Regarding current trading prices, TVTX is priced at $40.08, while RXDX trades at $199.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas RXDX's P/E ratio is -56.47. In terms of profitability, TVTX's ROE is -0.79%, compared to RXDX's ROE of -0.31%. Regarding short-term risk, TVTX is more volatile compared to RXDX. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check RXDX's competition here
TVTX vs TECH Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, TECH has a market cap of 9.3B. Regarding current trading prices, TVTX is priced at $40.08, while TECH trades at $60.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas TECH's P/E ratio is 111.75. In terms of profitability, TVTX's ROE is -0.79%, compared to TECH's ROE of +0.04%. Regarding short-term risk, TVTX is more volatile compared to TECH. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check TECH's competition here
TVTX vs PCVX Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, PCVX has a market cap of 9B. Regarding current trading prices, TVTX is priced at $40.08, while PCVX trades at $62.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas PCVX's P/E ratio is -11.07. In terms of profitability, TVTX's ROE is -0.79%, compared to PCVX's ROE of -0.26%. Regarding short-term risk, TVTX is more volatile compared to PCVX. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check PCVX's competition here
TVTX vs IMGN Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, IMGN has a market cap of 8.7B. Regarding current trading prices, TVTX is priced at $40.08, while IMGN trades at $31.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas IMGN's P/E ratio is -111.55. In terms of profitability, TVTX's ROE is -0.79%, compared to IMGN's ROE of -0.93%. Regarding short-term risk, TVTX is more volatile compared to IMGN. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check IMGN's competition here
TVTX vs BPMC Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, BPMC has a market cap of 8.4B. Regarding current trading prices, TVTX is priced at $40.08, while BPMC trades at $129.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas BPMC's P/E ratio is -51.58. In terms of profitability, TVTX's ROE is -0.79%, compared to BPMC's ROE of -0.15%. Regarding short-term risk, TVTX is more volatile compared to BPMC. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check BPMC's competition here
TVTX vs CYTK Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, CYTK has a market cap of 8.2B. Regarding current trading prices, TVTX is priced at $40.08, while CYTK trades at $66.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas CYTK's P/E ratio is -10.20. In terms of profitability, TVTX's ROE is -0.79%, compared to CYTK's ROE of +1.73%. Regarding short-term risk, TVTX is more volatile compared to CYTK. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check CYTK's competition here
TVTX vs HALO Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, HALO has a market cap of 8.2B. Regarding current trading prices, TVTX is priced at $40.08, while HALO trades at $70.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas HALO's P/E ratio is 27.07. In terms of profitability, TVTX's ROE is -0.79%, compared to HALO's ROE of +0.93%. Regarding short-term risk, TVTX is more volatile compared to HALO. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check HALO's competition here
TVTX vs CERE Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, CERE has a market cap of 8.2B. Regarding current trading prices, TVTX is priced at $40.08, while CERE trades at $44.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas CERE's P/E ratio is -16.47. In terms of profitability, TVTX's ROE is -0.79%, compared to CERE's ROE of -0.72%. Regarding short-term risk, TVTX is more volatile compared to CERE. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check CERE's competition here
TVTX vs KRYS Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, KRYS has a market cap of 8B. Regarding current trading prices, TVTX is priced at $40.08, while KRYS trades at $275.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas KRYS's P/E ratio is 40.09. In terms of profitability, TVTX's ROE is -0.79%, compared to KRYS's ROE of +0.19%. Regarding short-term risk, TVTX is more volatile compared to KRYS. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check KRYS's competition here
TVTX vs IBRX Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, IBRX has a market cap of 7.9B. Regarding current trading prices, TVTX is priced at $40.08, while IBRX trades at $8.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas IBRX's P/E ratio is -20.26. In terms of profitability, TVTX's ROE is -0.79%, compared to IBRX's ROE of +0.64%. Regarding short-term risk, TVTX is less volatile compared to IBRX. This indicates potentially lower risk in terms of short-term price fluctuations for TVTX.Check IBRX's competition here
TVTX vs NUVL Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, NUVL has a market cap of 7.9B. Regarding current trading prices, TVTX is priced at $40.08, while NUVL trades at $107.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas NUVL's P/E ratio is -18.41. In terms of profitability, TVTX's ROE is -0.79%, compared to NUVL's ROE of -0.42%. Regarding short-term risk, TVTX is more volatile compared to NUVL. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check NUVL's competition here
TVTX vs ABVX Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, ABVX has a market cap of 7.9B. Regarding current trading prices, TVTX is priced at $40.08, while ABVX trades at $116.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas ABVX's P/E ratio is -21.34. In terms of profitability, TVTX's ROE is -0.79%, compared to ABVX's ROE of -1.59%. Regarding short-term risk, TVTX is more volatile compared to ABVX. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check ABVX's competition here
TVTX vs MTSR Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, MTSR has a market cap of 7.4B. Regarding current trading prices, TVTX is priced at $40.08, while MTSR trades at $70.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas MTSR's P/E ratio is -23.58. In terms of profitability, TVTX's ROE is -0.79%, compared to MTSR's ROE of -0.80%. Regarding short-term risk, TVTX is more volatile compared to MTSR. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check MTSR's competition here
TVTX vs PRAX Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, PRAX has a market cap of 7.2B. Regarding current trading prices, TVTX is priced at $40.08, while PRAX trades at $344.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas PRAX's P/E ratio is -25.43. In terms of profitability, TVTX's ROE is -0.79%, compared to PRAX's ROE of -0.59%. Regarding short-term risk, TVTX is more volatile compared to PRAX. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check PRAX's competition here
TVTX vs KYMR Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, KYMR has a market cap of 7.2B. Regarding current trading prices, TVTX is priced at $40.08, while KYMR trades at $88.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas KYMR's P/E ratio is -23.77. In terms of profitability, TVTX's ROE is -0.79%, compared to KYMR's ROE of -0.29%. Regarding short-term risk, TVTX is more volatile compared to KYMR. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check KYMR's competition here
TVTX vs MRUS Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, MRUS has a market cap of 6.8B. Regarding current trading prices, TVTX is priced at $40.08, while MRUS trades at $90.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas MRUS's P/E ratio is -17.05. In terms of profitability, TVTX's ROE is -0.79%, compared to MRUS's ROE of -0.51%. Regarding short-term risk, TVTX is more volatile compared to MRUS. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check MRUS's competition here
TVTX vs PTGX Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, PTGX has a market cap of 6.8B. Regarding current trading prices, TVTX is priced at $40.08, while PTGX trades at $106.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas PTGX's P/E ratio is -51.70. In terms of profitability, TVTX's ROE is -0.79%, compared to PTGX's ROE of -0.20%. Regarding short-term risk, TVTX is more volatile compared to PTGX. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check PTGX's competition here
TVTX vs ACLX Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, ACLX has a market cap of 6.7B. Regarding current trading prices, TVTX is priced at $40.08, while ACLX trades at $115.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas ACLX's P/E ratio is -28.27. In terms of profitability, TVTX's ROE is -0.79%, compared to ACLX's ROE of -0.55%. Regarding short-term risk, TVTX is more volatile compared to ACLX. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check ACLX's competition here
TVTX vs BLTE Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, BLTE has a market cap of 6.6B. Regarding current trading prices, TVTX is priced at $40.08, while BLTE trades at $162.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas BLTE's P/E ratio is -71.62. In terms of profitability, TVTX's ROE is -0.79%, compared to BLTE's ROE of -0.23%. Regarding short-term risk, TVTX is more volatile compared to BLTE. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check BLTE's competition here
TVTX vs RETA Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, RETA has a market cap of 6.6B. Regarding current trading prices, TVTX is priced at $40.08, while RETA trades at $172.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas RETA's P/E ratio is -66.29. In terms of profitability, TVTX's ROE is -0.79%, compared to RETA's ROE of +0.47%. Regarding short-term risk, TVTX is more volatile compared to RETA. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check RETA's competition here
TVTX vs CGON Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, CGON has a market cap of 6.2B. Regarding current trading prices, TVTX is priced at $40.08, while CGON trades at $72.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas CGON's P/E ratio is -35.30. In terms of profitability, TVTX's ROE is -0.79%, compared to CGON's ROE of -0.23%. Regarding short-term risk, TVTX is more volatile compared to CGON. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check CGON's competition here
TVTX vs RYTM Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, RYTM has a market cap of 6.1B. Regarding current trading prices, TVTX is priced at $40.08, while RYTM trades at $88.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas RYTM's P/E ratio is -28.52. In terms of profitability, TVTX's ROE is -0.79%, compared to RYTM's ROE of -1.79%. Regarding short-term risk, TVTX is more volatile compared to RYTM. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check RYTM's competition here
TVTX vs COGT Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, COGT has a market cap of 6B. Regarding current trading prices, TVTX is priced at $40.08, while COGT trades at $37.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas COGT's P/E ratio is -17.25. In terms of profitability, TVTX's ROE is -0.79%, compared to COGT's ROE of -1.00%. Regarding short-term risk, TVTX is more volatile compared to COGT. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check COGT's competition here
TVTX vs PTCT Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, PTCT has a market cap of 6B. Regarding current trading prices, TVTX is priced at $40.08, while PTCT trades at $72.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas PTCT's P/E ratio is 8.44. In terms of profitability, TVTX's ROE is -0.79%, compared to PTCT's ROE of -3.62%. Regarding short-term risk, TVTX is more volatile compared to PTCT. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check PTCT's competition here
TVTX vs CAI Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, CAI has a market cap of 6B. Regarding current trading prices, TVTX is priced at $40.08, while CAI trades at $21.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas CAI's P/E ratio is -6.57. In terms of profitability, TVTX's ROE is -0.79%, compared to CAI's ROE of +0.25%. Regarding short-term risk, TVTX is more volatile compared to CAI. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check CAI's competition here
TVTX vs IMVT Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, IMVT has a market cap of 6B. Regarding current trading prices, TVTX is priced at $40.08, while IMVT trades at $28.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas IMVT's P/E ratio is -10.97. In terms of profitability, TVTX's ROE is -0.79%, compared to IMVT's ROE of -0.66%. Regarding short-term risk, TVTX is more volatile compared to IMVT. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check IMVT's competition here
TVTX vs CELC Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, CELC has a market cap of 5.9B. Regarding current trading prices, TVTX is priced at $40.08, while CELC trades at $121.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas CELC's P/E ratio is -32.23. In terms of profitability, TVTX's ROE is -0.79%, compared to CELC's ROE of -2.03%. Regarding short-term risk, TVTX is more volatile compared to CELC. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check CELC's competition here
TVTX vs CNTA Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, CNTA has a market cap of 5.9B. Regarding current trading prices, TVTX is priced at $40.08, while CNTA trades at $39.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas CNTA's P/E ratio is -27.16. In terms of profitability, TVTX's ROE is -0.79%, compared to CNTA's ROE of -0.51%. Regarding short-term risk, TVTX is more volatile compared to CNTA. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check CNTA's competition here
TVTX vs ERAS Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, ERAS has a market cap of 5.9B. Regarding current trading prices, TVTX is priced at $40.08, while ERAS trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas ERAS's P/E ratio is -43.20. In terms of profitability, TVTX's ROE is -0.79%, compared to ERAS's ROE of -0.34%. Regarding short-term risk, TVTX is less volatile compared to ERAS. This indicates potentially lower risk in terms of short-term price fluctuations for TVTX.Check ERAS's competition here
TVTX vs ALKS Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, ALKS has a market cap of 5.8B. Regarding current trading prices, TVTX is priced at $40.08, while ALKS trades at $34.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas ALKS's P/E ratio is 24.15. In terms of profitability, TVTX's ROE is -0.79%, compared to ALKS's ROE of +0.14%. Regarding short-term risk, TVTX is more volatile compared to ALKS. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check ALKS's competition here
TVTX vs SRRK Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, SRRK has a market cap of 5.7B. Regarding current trading prices, TVTX is priced at $40.08, while SRRK trades at $48.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas SRRK's P/E ratio is -15.19. In terms of profitability, TVTX's ROE is -0.79%, compared to SRRK's ROE of -1.46%. Regarding short-term risk, TVTX is more volatile compared to SRRK. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check SRRK's competition here
TVTX vs TGTX Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, TGTX has a market cap of 5.6B. Regarding current trading prices, TVTX is priced at $40.08, while TGTX trades at $36.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas TGTX's P/E ratio is 12.75. In terms of profitability, TVTX's ROE is -0.79%, compared to TGTX's ROE of +1.01%. Regarding short-term risk, TVTX is less volatile compared to TGTX. This indicates potentially lower risk in terms of short-term price fluctuations for TVTX.Check TGTX's competition here
TVTX vs CDTX Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, CDTX has a market cap of 5.6B. Regarding current trading prices, TVTX is priced at $40.08, while CDTX trades at $221.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas CDTX's P/E ratio is -19.77. In terms of profitability, TVTX's ROE is -0.79%, compared to CDTX's ROE of -0.60%. Regarding short-term risk, TVTX is more volatile compared to CDTX. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check CDTX's competition here
TVTX vs CRSP Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, CRSP has a market cap of 5.6B. Regarding current trading prices, TVTX is priced at $40.08, while CRSP trades at $57.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas CRSP's P/E ratio is -8.96. In terms of profitability, TVTX's ROE is -0.79%, compared to CRSP's ROE of -0.32%. Regarding short-term risk, TVTX is more volatile compared to CRSP. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check CRSP's competition here
TVTX vs ABCM Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, ABCM has a market cap of 5.5B. Regarding current trading prices, TVTX is priced at $40.08, while ABCM trades at $23.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas ABCM's P/E ratio is 2399.00. In terms of profitability, TVTX's ROE is -0.79%, compared to ABCM's ROE of -0.01%. Regarding short-term risk, TVTX is more volatile compared to ABCM. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check ABCM's competition here
TVTX vs ISEE Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, ISEE has a market cap of 5.5B. Regarding current trading prices, TVTX is priced at $40.08, while ISEE trades at $39.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas ISEE's P/E ratio is -22.44. In terms of profitability, TVTX's ROE is -0.79%, compared to ISEE's ROE of -0.39%. Regarding short-term risk, TVTX is more volatile compared to ISEE. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check ISEE's competition here
TVTX vs APLS Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, APLS has a market cap of 5.2B. Regarding current trading prices, TVTX is priced at $40.08, while APLS trades at $40.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas APLS's P/E ratio is 227.22. In terms of profitability, TVTX's ROE is -0.79%, compared to APLS's ROE of +0.08%. Regarding short-term risk, TVTX is more volatile compared to APLS. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check APLS's competition here
TVTX vs FBIOX Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, FBIOX has a market cap of 5.2B. Regarding current trading prices, TVTX is priced at $40.08, while FBIOX trades at $25.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas FBIOX's P/E ratio is N/A. In terms of profitability, TVTX's ROE is -0.79%, compared to FBIOX's ROE of +0.00%. Regarding short-term risk, TVTX is more volatile compared to FBIOX. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check FBIOX's competition here
TVTX vs APGE Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, APGE has a market cap of 5.2B. Regarding current trading prices, TVTX is priced at $40.08, while APGE trades at $91.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas APGE's P/E ratio is -21.85. In terms of profitability, TVTX's ROE is -0.79%, compared to APGE's ROE of -0.37%. Regarding short-term risk, TVTX is less volatile compared to APGE. This indicates potentially lower risk in terms of short-term price fluctuations for TVTX.Check APGE's competition here
TVTX vs MIRM Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, MIRM has a market cap of 4.9B. Regarding current trading prices, TVTX is priced at $40.08, while MIRM trades at $95.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas MIRM's P/E ratio is -208.40. In terms of profitability, TVTX's ROE is -0.79%, compared to MIRM's ROE of -0.09%. Regarding short-term risk, TVTX is less volatile compared to MIRM. This indicates potentially lower risk in terms of short-term price fluctuations for TVTX.Check MIRM's competition here
TVTX vs CORT Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, CORT has a market cap of 4.9B. Regarding current trading prices, TVTX is priced at $40.08, while CORT trades at $45.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas CORT's P/E ratio is 56.29. In terms of profitability, TVTX's ROE is -0.79%, compared to CORT's ROE of +0.15%. Regarding short-term risk, TVTX is more volatile compared to CORT. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check CORT's competition here
TVTX vs TERN Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, TERN has a market cap of 4.7B. Regarding current trading prices, TVTX is priced at $40.08, while TERN trades at $52.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas TERN's P/E ratio is -51.12. In terms of profitability, TVTX's ROE is -0.79%, compared to TERN's ROE of -0.20%. Regarding short-term risk, TVTX is more volatile compared to TERN. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check TERN's competition here
TVTX vs XENE Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, XENE has a market cap of 4.7B. Regarding current trading prices, TVTX is priced at $40.08, while XENE trades at $57.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas XENE's P/E ratio is -13.69. In terms of profitability, TVTX's ROE is -0.79%, compared to XENE's ROE of -0.56%. Regarding short-term risk, TVTX is less volatile compared to XENE. This indicates potentially lower risk in terms of short-term price fluctuations for TVTX.Check XENE's competition here
TVTX vs LGND Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, LGND has a market cap of 4.6B. Regarding current trading prices, TVTX is priced at $40.08, while LGND trades at $230.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas LGND's P/E ratio is 37.82. In terms of profitability, TVTX's ROE is -0.79%, compared to LGND's ROE of +0.14%. Regarding short-term risk, TVTX is less volatile compared to LGND. This indicates potentially lower risk in terms of short-term price fluctuations for TVTX.Check LGND's competition here
TVTX vs FOLD Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, FOLD has a market cap of 4.5B. Regarding current trading prices, TVTX is priced at $40.08, while FOLD trades at $14.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas FOLD's P/E ratio is -160.67. In terms of profitability, TVTX's ROE is -0.79%, compared to FOLD's ROE of -0.12%. Regarding short-term risk, TVTX is more volatile compared to FOLD. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check FOLD's competition here
TVTX vs AKRO Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, AKRO has a market cap of 4.5B. Regarding current trading prices, TVTX is priced at $40.08, while AKRO trades at $54.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas AKRO's P/E ratio is -14.57. In terms of profitability, TVTX's ROE is -0.79%, compared to AKRO's ROE of -0.31%. Regarding short-term risk, TVTX is more volatile compared to AKRO. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check AKRO's competition here
TVTX vs ALPN Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, ALPN has a market cap of 4.5B. Regarding current trading prices, TVTX is priced at $40.08, while ALPN trades at $64.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas ALPN's P/E ratio is -101.52. In terms of profitability, TVTX's ROE is -0.79%, compared to ALPN's ROE of -0.13%. Regarding short-term risk, TVTX is more volatile compared to ALPN. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check ALPN's competition here
TVTX vs SYRE Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, SYRE has a market cap of 4.4B. Regarding current trading prices, TVTX is priced at $40.08, while SYRE trades at $73.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas SYRE's P/E ratio is -36.87. In terms of profitability, TVTX's ROE is -0.79%, compared to SYRE's ROE of -0.29%. Regarding short-term risk, TVTX is more volatile compared to SYRE. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check SYRE's competition here
TVTX vs CRNX Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, CRNX has a market cap of 4.3B. Regarding current trading prices, TVTX is priced at $40.08, while CRNX trades at $40.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas CRNX's P/E ratio is -8.28. In terms of profitability, TVTX's ROE is -0.79%, compared to CRNX's ROE of -0.41%. Regarding short-term risk, TVTX is more volatile compared to CRNX. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check CRNX's competition here
TVTX vs OPT Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, OPT has a market cap of 4.2B. Regarding current trading prices, TVTX is priced at $40.08, while OPT trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas OPT's P/E ratio is -1.52. In terms of profitability, TVTX's ROE is -0.79%, compared to OPT's ROE of +0.88%. Regarding short-term risk, TVTX is more volatile compared to OPT. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check OPT's competition here
TVTX vs MRTX Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, MRTX has a market cap of 4.1B. Regarding current trading prices, TVTX is priced at $40.08, while MRTX trades at $58.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas MRTX's P/E ratio is -4.82. In terms of profitability, TVTX's ROE is -0.79%, compared to MRTX's ROE of -0.62%. Regarding short-term risk, TVTX is more volatile compared to MRTX. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check MRTX's competition here
TVTX vs VKTX Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, VKTX has a market cap of 4.1B. Regarding current trading prices, TVTX is priced at $40.08, while VKTX trades at $35.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas VKTX's P/E ratio is -11.03. In terms of profitability, TVTX's ROE is -0.79%, compared to VKTX's ROE of -0.48%. Regarding short-term risk, TVTX is more volatile compared to VKTX. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check VKTX's competition here
TVTX vs NAMS Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, NAMS has a market cap of 4B. Regarding current trading prices, TVTX is priced at $40.08, while NAMS trades at $34.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas NAMS's P/E ratio is -20.16. In terms of profitability, TVTX's ROE is -0.79%, compared to NAMS's ROE of -0.27%. Regarding short-term risk, TVTX is less volatile compared to NAMS. This indicates potentially lower risk in terms of short-term price fluctuations for TVTX.Check NAMS's competition here
TVTX vs LEGN Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, LEGN has a market cap of 3.9B. Regarding current trading prices, TVTX is priced at $40.08, while LEGN trades at $25.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas LEGN's P/E ratio is -13.07. In terms of profitability, TVTX's ROE is -0.79%, compared to LEGN's ROE of -0.29%. Regarding short-term risk, TVTX is less volatile compared to LEGN. This indicates potentially lower risk in terms of short-term price fluctuations for TVTX.Check LEGN's competition here
TVTX vs ACAD Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, ACAD has a market cap of 3.8B. Regarding current trading prices, TVTX is priced at $40.08, while ACAD trades at $22.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas ACAD's P/E ratio is 9.64. In terms of profitability, TVTX's ROE is -0.79%, compared to ACAD's ROE of +0.42%. Regarding short-term risk, TVTX is more volatile compared to ACAD. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check ACAD's competition here
TVTX vs RYZB Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, RYZB has a market cap of 3.8B. Regarding current trading prices, TVTX is priced at $40.08, while RYZB trades at $62.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas RYZB's P/E ratio is -57.86. In terms of profitability, TVTX's ROE is -0.79%, compared to RYZB's ROE of +0.83%. Regarding short-term risk, TVTX is more volatile compared to RYZB. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check RYZB's competition here
TVTX vs CBAY Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, CBAY has a market cap of 3.7B. Regarding current trading prices, TVTX is priced at $40.08, while CBAY trades at $32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas CBAY's P/E ratio is -32.81. In terms of profitability, TVTX's ROE is -0.79%, compared to CBAY's ROE of -0.64%. Regarding short-term risk, TVTX is more volatile compared to CBAY. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check CBAY's competition here
TVTX vs EWTX Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, EWTX has a market cap of 3.7B. Regarding current trading prices, TVTX is priced at $40.08, while EWTX trades at $34.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas EWTX's P/E ratio is -21.12. In terms of profitability, TVTX's ROE is -0.79%, compared to EWTX's ROE of -0.32%. Regarding short-term risk, TVTX is more volatile compared to EWTX. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check EWTX's competition here
TVTX vs TLX Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, TLX has a market cap of 3.6B. Regarding current trading prices, TVTX is priced at $40.08, while TLX trades at $10.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas TLX's P/E ratio is -537.00. In terms of profitability, TVTX's ROE is -0.79%, compared to TLX's ROE of -0.02%. Regarding short-term risk, TVTX is more volatile compared to TLX. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check TLX's competition here
TVTX vs DNTH Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, DNTH has a market cap of 3.6B. Regarding current trading prices, TVTX is priced at $40.08, while DNTH trades at $92.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas DNTH's P/E ratio is -22.20. In terms of profitability, TVTX's ROE is -0.79%, compared to DNTH's ROE of +0.00%. Regarding short-term risk, TVTX is more volatile compared to DNTH. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check DNTH's competition here
TVTX vs SWTX Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, SWTX has a market cap of 3.5B. Regarding current trading prices, TVTX is priced at $40.08, while SWTX trades at $46.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas SWTX's P/E ratio is -13.78. In terms of profitability, TVTX's ROE is -0.79%, compared to SWTX's ROE of -0.36%. Regarding short-term risk, TVTX is more volatile compared to SWTX. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check SWTX's competition here
TVTX vs LQDA Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, LQDA has a market cap of 3.5B. Regarding current trading prices, TVTX is priced at $40.08, while LQDA trades at $37.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas LQDA's P/E ratio is -49.34. In terms of profitability, TVTX's ROE is -0.79%, compared to LQDA's ROE of -2.09%. Regarding short-term risk, TVTX is less volatile compared to LQDA. This indicates potentially lower risk in terms of short-term price fluctuations for TVTX.Check LQDA's competition here
TVTX vs DYN Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, DYN has a market cap of 3.4B. Regarding current trading prices, TVTX is priced at $40.08, while DYN trades at $20.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas DYN's P/E ratio is -5.88. In terms of profitability, TVTX's ROE is -0.79%, compared to DYN's ROE of -0.61%. Regarding short-term risk, TVTX is less volatile compared to DYN. This indicates potentially lower risk in terms of short-term price fluctuations for TVTX.Check DYN's competition here
TVTX vs KNSA Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, KNSA has a market cap of 3.3B. Regarding current trading prices, TVTX is priced at $40.08, while KNSA trades at $43.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas KNSA's P/E ratio is 59.87. In terms of profitability, TVTX's ROE is -0.79%, compared to KNSA's ROE of +0.11%. Regarding short-term risk, TVTX is less volatile compared to KNSA. This indicates potentially lower risk in terms of short-term price fluctuations for TVTX.Check KNSA's competition here
TVTX vs DNLI Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, DNLI has a market cap of 3.3B. Regarding current trading prices, TVTX is priced at $40.08, while DNLI trades at $20.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas DNLI's P/E ratio is -6.93. In terms of profitability, TVTX's ROE is -0.79%, compared to DNLI's ROE of -0.50%. Regarding short-term risk, TVTX is more volatile compared to DNLI. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check DNLI's competition here
TVTX vs CPRX Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, CPRX has a market cap of 3.2B. Regarding current trading prices, TVTX is priced at $40.08, while CPRX trades at $26.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas CPRX's P/E ratio is 15.63. In terms of profitability, TVTX's ROE is -0.79%, compared to CPRX's ROE of +0.24%. Regarding short-term risk, TVTX is more volatile compared to CPRX. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check CPRX's competition here
TVTX vs BEAM Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, BEAM has a market cap of 3.2B. Regarding current trading prices, TVTX is priced at $40.08, while BEAM trades at $31.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas BEAM's P/E ratio is -38.75. In terms of profitability, TVTX's ROE is -0.79%, compared to BEAM's ROE of -0.07%. Regarding short-term risk, TVTX is more volatile compared to BEAM. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check BEAM's competition here
TVTX vs TNGX Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, TNGX has a market cap of 3.1B. Regarding current trading prices, TVTX is priced at $40.08, while TNGX trades at $27.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas TNGX's P/E ratio is -30.62. In terms of profitability, TVTX's ROE is -0.79%, compared to TNGX's ROE of -0.50%. Regarding short-term risk, TVTX is less volatile compared to TNGX. This indicates potentially lower risk in terms of short-term price fluctuations for TVTX.Check TNGX's competition here
TVTX vs ALMS Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, ALMS has a market cap of 3.1B. Regarding current trading prices, TVTX is priced at $40.08, while ALMS trades at $24.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas ALMS's P/E ratio is -8.74. In terms of profitability, TVTX's ROE is -0.79%, compared to ALMS's ROE of -0.73%. Regarding short-term risk, TVTX is more volatile compared to ALMS. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check ALMS's competition here
TVTX vs ARQT Comparison April 2026
TVTX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TVTX stands at 3.8B. In comparison, ARQT has a market cap of 3B. Regarding current trading prices, TVTX is priced at $40.08, while ARQT trades at $24.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TVTX currently has a P/E ratio of -71.53, whereas ARQT's P/E ratio is -188.69. In terms of profitability, TVTX's ROE is -0.79%, compared to ARQT's ROE of -0.10%. Regarding short-term risk, TVTX is more volatile compared to ARQT. This indicates potentially higher risk in terms of short-term price fluctuations for TVTX.Check ARQT's competition here